STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation course tested to ease side effects after prostate surgery
Disease control CompletedThis study tested whether a shorter, more intense course of radiation (given over 5 weeks) was as effective and caused fewer side effects than the standard longer course (over 7 weeks) for men who had surgery for prostate cancer. Nearly 300 men participated and were randomly assi…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 02, 2026 01:57 UTC
-
Study aims to stop prostate Cancer's return with Triple-Threat therapy
Disease control CompletedThis study tested whether adding a chemotherapy drug (docetaxel) to the standard post-surgery treatment of hormone therapy and radiation could better prevent prostate cancer from coming back. It involved over 600 men who had surgery for prostate cancer but were at high risk of re…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 02, 2026 01:56 UTC
-
New drug combo tested to stall advanced prostate cancer before surgery
Disease control CompletedThis study tested if adding a drug called axitinib to standard hormone-blocking therapy before surgery could better control prostate cancer that had spread to lymph nodes. It involved 73 men who were randomly assigned to receive either the standard therapy alone or the standard t…
Matched conditions: STAGE III PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC